Not a good buy right now for an impatient entry: price is extended into resistance (R1 ~96.29 / R2 ~98.62) while insider selling has surged.
Trend is still bullish (stacked moving averages), so this is more of a “wait for a better pullback” than a bearish call.
If you must act immediately, risk/reward is not favorable at $95.17 vs nearby support (~92.51 pivot), with model-implied next-week downside bias (-3.36%).
Positioning/sentiment: Open interest put/call at 0.72 implies more calls than puts outstanding (mildly bullish).
Flow: Put volume is 0 today while call volume is 113 (put/call volume 0.0) → today’s activity is overwhelmingly call-sided.
Volatility: IV 30d ~35.87 vs HV ~49.43 (options priced relatively cheap vs realized); IV percentile 19.12 / IV rank 4.35 indicates low implied vol vs its own history.
Activity spike: Today’s volume ~452% of 30-day average and OI participation is elevated (today vs OI avg ~124.4), suggesting a notable options-event day—directionally skewed bullish due to calls.
Technical Summary
Sell
3
Buy
9
Positive Catalysts
is strong: revenue +7.9% YoY, net income +34.73% YoY, EPS +47.34% YoY.
Neutral/Negative Catalysts
Insiders are selling aggressively: selling amount increased 253.14% over the last month (notable negative signal vs buying now).
Price is pressing into resistance (R1 ~96.29 nearby), while momentum (MACD histogram) is contracting.
No fresh news catalysts in the past week to justify chasing strength.
No hedge-fund accumulation signal: hedge funds reported as neutral over the last quarter.
2025/Q4: Net income $28.857M (+34.73% YoY) indicating strong operating leverage / profitability improvement.
2025/Q4: EPS $2.77 (+47.34% YoY), a clear acceleration in earnings power.
Overall: Growth trends are positive and supportive of a higher multiple, but timing is less attractive given technical/resistance + insider-selling backdrop.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Latest update (2026-01-22): Keefe Bruyette raised price target to $105 from $90 and maintained Outperform.
Wall Street pro view (pros): improving earnings trajectory, supportive analyst target above current price (~10% upside to $105).
Wall Street con view (cons): current setup is more “buy dips” than “chase,” especially with heavy insider selling and no new near-term catalysts.
Influential/political trading check: No recent congress trading data available; no politician activity indicated in the provided data.
Wall Street analysts forecast MCB stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for MCB is 88 USD with a low forecast of 86 USD and a high forecast of 90 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
Wall Street analysts forecast MCB stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for MCB is 88 USD with a low forecast of 86 USD and a high forecast of 90 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 95.210
Low
86
Averages
88
High
90
Current: 95.210
Low
86
Averages
88
High
90
Keefe Bruyette
Outperform
maintain
$90 -> $105
AI Analysis
2026-01-22
Reason
Keefe Bruyette
Price Target
$90 -> $105
AI Analysis
2026-01-22
maintain
Outperform
Reason
Keefe Bruyette raised the firm's price target on Metropolitan Bank to $105 from $90 and keeps an Outperform rating on the shares.
Keefe Bruyette
Outperform
to
NULL
downgrade
$95 -> $90
2025-10-27
Reason
Keefe Bruyette
Price Target
$95 -> $90
2025-10-27
downgrade
Outperform
to
NULL
Reason
Keefe Bruyette lowered the firm's price target on Metropolitan Bank to $90 from $95 and keeps an Outperform rating on the shares.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for MCB
